Editorial Expression of Concern to: British Journal of Cancer https://doi.org/10.1038/sj.bjc.6605499, published online 05 January 2010
The Editor-in-Chief would like to alert the readers that concerns have been raised regarding the images presented in Fig. 3 of this article, specifically:
-
Fig. 3C, pAKT, Erb-hcAb and Erb-hRNase seem to be highly similar to one another
-
Fig. 3C, Actin and Fig. 2C, Actin [1] appear to be highly similar
The authors had been given the opportunity to address the concerns raised; however, they did not respond to the Publisher’s correspondence about this Editorial Expression of concern.
Readers are therefore advised to interpret these results with caution.
References
Rosa R, Damiano V, Nappi L, Formisano L, Massari F, Scarpa A, et al. RETRACTED ARTICLE: Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer. Br J Cancer. 2013;109:686–93. https://doi.org/10.1038/bjc.2013.360.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gelardi, T., Damiano, V., Rosa, R. et al. Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours. Br J Cancer 134, 355 (2026). https://doi.org/10.1038/s41416-025-03337-2
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41416-025-03337-2